Pharsight

Veroscience patents expiration

1. Cycloset patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8137992 VEROSCIENCE Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof
Jul, 2023

(2 months ago)

US8137994 VEROSCIENCE Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof
Jul, 2023

(2 months ago)

US8137993 VEROSCIENCE Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof
Jul, 2023

(2 months ago)

US7888310 VEROSCIENCE Methods of identifying responders to dopamine agonist therapy
Jul, 2023

(2 months ago)

US9895422 VEROSCIENCE Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders
Jun, 2030

(6 years from now)

US9352025 VEROSCIENCE Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders
Jun, 2030

(6 years from now)

US10688155 VEROSCIENCE Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders
Jun, 2030

(6 years from now)

US8877708 VEROSCIENCE Combination of dopamine agonists plus first phase secretagogues for the treatment of metabolic disorders
Jun, 2030

(6 years from now)

US8613947 VEROSCIENCE Bromocriptine formulations
Apr, 2032

(8 years from now)

US9700555 VEROSCIENCE Bromocriptine formulations
Apr, 2032

(8 years from now)

US9993474 VEROSCIENCE Bromocriptine formulations
Apr, 2032

(8 years from now)

US9192576 VEROSCIENCE Bromocriptine formulations
Apr, 2032

(8 years from now)

US9522117 VEROSCIENCE Bromocriptine formulations
Apr, 2032

(8 years from now)

US10688094 VEROSCIENCE Bromocriptine formulations
Apr, 2032

(8 years from now)

US11000522 VEROSCIENCE Bromocriptine formulations
Apr, 2032

(8 years from now)

US8431155 VEROSCIENCE Bromocriptine formulations
Apr, 2032

(8 years from now)

Drugs and Companies using BROMOCRIPTINE MESYLATE ingredient

Market Authorisation Date: 05 May, 2009

Treatment: Improvements of glycemic control in individuals with type 2 diabetes who have one or more specified cardiovascular risk factors; Adjunct to diet and exercise to improve glycemic control in adults with...

Dosage: TABLET;ORAL

More Information on Dosage

CYCLOSET family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic